260601AI + Pharmaceuticals

Project Overview

One of China's "Four Little Dragons" in AI-powered drug screening and knowledge delivery

Business Model

Eliminate the high costs, low efficiency, and frequent errors of legacy CRO+SaaS+database models. Automate repetitive tasks to reduce costly manual work, lowering drug development expenses and timelines for pharmaceutical companies. This accelerates market launch, driving higher sales. A highly efficient R&D tool for the pharmaceutical industry.

Market Opportunities

Currently, our domestic and international clients include over 1000+ leading pharmaceutical companies such as Bayer, Merck & Co., Roche, Merck KGaA, Johnson & Johnson, GlaxoSmithKline, BeiGene, Yuanda Pharmaceutical, and Livzon Pharma, with more than 300 active clients. Over 3 submissions have been processed. Our international expansion is thriving, featuring multi-center operations with operational entities in Japan and Singapore, securing high-value overseas clients.

Funding Plan